Robert J. Bitterman - 30 Jun 2023 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
President & CEO, Director
Signature
Caitlin Kontulis, attorney-in-fact
Issuer symbol
PHIO
Transactions as of
30 Jun 2023
Net transactions value
+$5,720
Form type
4
Filing time
05 Jul 2023, 18:00:29 UTC
Previous filing
22 Feb 2023
Next filing
03 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Purchase $2,880 +1,000 +5.8% $2.88 18,211 30 Jun 2023 Direct F1
transaction PHIO Common stock, $0.0001 par value Purchase $2,840 +1,000 +5.5% $2.84 19,211 01 Jul 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares of common stock underlying unvested restricted stock units.